Signifor (pasireotide subcutaneous injection) — Medica

Initial criteria

• age ≥ 18 years
• According to the prescriber, the patient is not a candidate for surgery or surgery has not been curative OR Patient is awaiting surgery for endogenous Cushing’s syndrome OR Patient is awaiting therapeutic response after radiotherapy for endogenous Cushing’s syndrome
• The medication is prescribed by or in consultation with an endocrinologist or a physician who specializes in the treatment of Cushing’s syndrome

Approval duration

1 year